The long term goal of this Pathway to Independence Award (PIA) is to develop a program of research focused on increasing the effectiveness and reach of smoking cessation interventions for adults with serious mental illness (SMI) using mobile health technology. This long term goal will be achieved via a 5-year training and research plan that will launch Dr. Roger Vilardaga's independent program of research and academic career. The career objectives of this award are to: (1) become an expert in the science of behavioral smoking cessation interventions;(2) master the development, testing and implementation of mobile health interventions;(3) become an expert in the implementation of clinical trials in people with SMI. These career objectives will be achieved via formal coursework, trainings, seminars, national conferences, mentorship and research experience. The knowledge derived from this training plan will equip the PI to pursue the following aims.
The first aim, guided by an expert panel, is to adapt an existing Acceptance and Commitment Therapy smartphone application for smoking cessation (SmartQuit) to people with SMI, and develop a smartphone coaching guide for staff.
The second aim i s to conduct iterative usability testing of the resulting app (SmartQuit+) and coaching guide in a sample of 10 people with SMI. Finally, the third aim is to conduct a two-arm feasibility randomized trial that compares SmartQuit+ to an app based on best-practice smoking cessation guidelines (NCI QuitPal) in a sample of 90 people with SMI from a community-based setting. Both arms will include a low cost pharmacological intervention (nicotine replacement therapy). The primary feasibility outcomes in this trial (e.g., recruitment and retention rates) will determine a reliable methodological approach to conduct a fully-powered R01 trial. Dr. Jonathan Bricker will serve as primary mentor on this PIA, providing expertise in smoking cessation, ACT applied to smoking cessation, and mobile health interventions. The mentoring and consulting team of experts in SMI, smoking cessation, computer science and methods/statistics (Drs. Ries, Ziedonis, Saxon, Kientz and Atkins), will ensure that the PI receives the necessary support to successfully complete the proposed research. The training activities will take place at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle, two cutting-edge research institutions that will provide an excellent environment for completion of the PI's objectives. This study meets NIDA's major programmatic priorities of using innovative technologies and integrating behavioral and pharmacological interventions to improve substance use treatment and outcomes (NOT-DA-10-019). The study addresses a serious problem - high smoking rates in people with SMI-, and it proposes the delivery of a promising behavioral intervention for smoking cessation in a "real-world" setting using a wider reaching technology. This PIA will forge the PI's pathway to independence by laying the foundation for a career in mobile health interventions for smoking cessation in people with SMI.

Public Health Relevance

Smoking tobacco shortens the lifespan of adults with serious mental illness by 25 years and contributes to $317 billion healthcare expenditures and indirect loss of earnings and disability benefits. A new model to deliver more effective and wider reaching smoking cessation interventions in individuals with serious mental illness is highly needed. This project proposes to develop such model and test its initial feasibility.

National Institute of Health (NIH)
Career Transition Award (K99)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Crump, Aria
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Schools of Medicine
United States
Zip Code
Karkar, Ravi; Zia, Jasmine; Vilardaga, Roger et al. (2016) A framework for self-experimentation in personalized health. J Am Med Inform Assoc 23:440-8
Vilardaga, Roger; Rizo, Javier; Kientz, Julie A et al. (2016) User Experience Evaluation of a Smoking Cessation App in People With Serious Mental Illness. Nicotine Tob Res 18:1032-8
Heffner, Jaimee L; Vilardaga, Roger; Mercer, Laina D et al. (2015) Feature-level analysis of a novel smartphone application for smoking cessation. Am J Drug Alcohol Abuse 41:68-73
Lowe, Jessica M; McDonell, Michael G; Leickly, Emily et al. (2015) Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients. Alcohol Clin Exp Res 39:905-10
Jones, Helen A; Heffner, Jaimee L; Mercer, Laina et al. (2015) Web-based acceptance and commitment therapy smoking cessation treatment for smokers with depressive symptoms. J Dual Diagn 11:56-62
Leickly, Emily; McDonell, Michael G; Vilardaga, Roger et al. (2015) High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry. Am J Drug Alcohol Abuse 41:246-50
Zeng, Emily Y; Vilardaga, Roger; Heffner, Jaimee L et al. (2015) Predictors of Utilization of a Novel Smoking Cessation Smartphone App. Telemed J E Health 21:998-1004
Roth, Walter R; Vilardaga, Roger; Wolfe, Nathanael et al. (2014) Practical considerations in the design and development of smartphone apps for behavior change. J Contextual Behav Sci 3:269-272
Vilardaga, Roger; Heffner, Jaimee L; Mercer, Laina D et al. (2014) Do counselor techniques predict quitting during smoking cessation treatment? A component analysis of telephone-delivered Acceptance and Commitment Therapy. Behav Res Ther 61:89-95
Yadavaia, James E; Hayes, Steven C; Vilardaga, Roger (2014) Using Acceptance and Commitment Therapy to Increase Self-Compassion: A Randomized Controlled Trial. J Contextual Behav Sci 3:248-257

Showing the most recent 10 out of 11 publications